1. Home
  2. PLUR vs NXN Comparison

PLUR vs NXN Comparison

Compare PLUR & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUR
  • NXN
  • Stock Information
  • Founded
  • PLUR 2001
  • NXN 1992
  • Country
  • PLUR Israel
  • NXN United States
  • Employees
  • PLUR N/A
  • NXN N/A
  • Industry
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • NXN Trusts Except Educational Religious and Charitable
  • Sector
  • PLUR Health Care
  • NXN Finance
  • Exchange
  • PLUR Nasdaq
  • NXN Nasdaq
  • Market Cap
  • PLUR 41.9M
  • NXN 45.4M
  • IPO Year
  • PLUR N/A
  • NXN N/A
  • Fundamental
  • Price
  • PLUR $5.08
  • NXN $11.42
  • Analyst Decision
  • PLUR Strong Buy
  • NXN
  • Analyst Count
  • PLUR 1
  • NXN 0
  • Target Price
  • PLUR $12.00
  • NXN N/A
  • AVG Volume (30 Days)
  • PLUR 64.6K
  • NXN 9.7K
  • Earning Date
  • PLUR 05-13-2025
  • NXN 01-01-0001
  • Dividend Yield
  • PLUR N/A
  • NXN 4.23%
  • EPS Growth
  • PLUR N/A
  • NXN N/A
  • EPS
  • PLUR N/A
  • NXN 0.24
  • Revenue
  • PLUR $1,034,000.00
  • NXN N/A
  • Revenue This Year
  • PLUR $472.39
  • NXN N/A
  • Revenue Next Year
  • PLUR $254.29
  • NXN N/A
  • P/E Ratio
  • PLUR N/A
  • NXN $48.42
  • Revenue Growth
  • PLUR 203.23
  • NXN N/A
  • 52 Week Low
  • PLUR $3.33
  • NXN $10.64
  • 52 Week High
  • PLUR $7.13
  • NXN $12.45
  • Technical
  • Relative Strength Index (RSI)
  • PLUR 53.31
  • NXN 37.30
  • Support Level
  • PLUR $4.57
  • NXN $11.49
  • Resistance Level
  • PLUR $5.52
  • NXN $11.60
  • Average True Range (ATR)
  • PLUR 0.39
  • NXN 0.11
  • MACD
  • PLUR -0.02
  • NXN -0.02
  • Stochastic Oscillator
  • PLUR 47.27
  • NXN 3.39

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

About NXN Nuveen New York Select Tax-Free Income Portfolio

Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: